Dual Antiplatelet Therapy After Elective Coronary Artery Bypass Graft and Its Impact on Clinical Outcomes.

ABSTRACT:

Background

Dual antiplatelet therapy (DAPT) has demonstrated survival benefits in patients undergoing coronary artery bypass grafting (CABG) for acute coronary syndrome. The impact of DAPT in patients undergoing elective CABG remains underexplored.

Methods

This single-center retrospective observational study reviewed all CABG procedures performed between 2012 and 2015. The primary outcome measured was the difference in mortality (all-cause and cardiovascular) between patients receiving aspirin monotherapy and those on DAPT. Secondary outcomes included post-CABG acute coronary syndrome, cerebrovascular accident, and major adverse cardiovascular events.

Results

Among the 1828 patients who underwent elective CABG surgery, those who received DAPT had lower rates of all-ca

SUBMITTER: Ch IA 

PROVIDER: S-EPMC12167555 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature